The Alabama Innovation Corporation has awarded two University of Alabama at Birmingham startups with grants during a second round of Innovate Alabama Supplemental Grant awards. And the Innovate Alabama Supplemental Grant Program awards funds to Alabama-based companies that were granted Phase I or Phase II awards through the Federal Small Business Innovation Research Program or Federal Small Business Technology Transfer Program.
The eligible companies can apply to receive a match of up to 50% of their SBIR/STTR grants. And Phase I Award recipients may receive up to $100,000 while Phase II Award recipients may receive up to $250,000. This program awarded over $3 million in grants during this round of funding to 19 winners, 5 of which were in the Birmingham area.
Of those 5 local winners, the two UAB startups are:
— Adjuvax, LLC, which specializes in vaccine adjuvant discovery and development. And the $100,000 Adjuvax received from Innovate Alabama will be used to develop a new adjuvant formulation for various vaccines against infectious diseases.
— Tricorder Array Technologies received $250,000 to aid in developing the PenPal, which is a wireless device that collects environmental and mouse squeaks in research cages, to understand the behavior and environment influence on animal studies.
Adjuvax and Tricorder Array Technologies join 7 UAB startups that received grants from the Alabama Innovation Corporation in 2022. And these startups include AeroNeph Therapeutics, AI Metrics, Endomimetics, Reliant Glycosciences, SunFire Biotechnologies, Trialtus Bioscience and TruSpin Nanomaterial Innovation.
